iBio Announces IBIO-600 Non-Human Primate Data Showing Extended Half-Life and Muscle Growth, and Interim In Vivo Results for First-in-Class Activin E Antibody, Advancing Cardiometabolic and Obesity Pipeline
Non-human primate pharmacokinetics data suggests IBIO-600, a potentially best-in-class long-acting anti-myostatin antibody,…
Woxsen University Releases MBA Placement Report 2025 showing Strong Growth in Industry Demand
HYDERABAD, India, April 1, 2025 /PRNewswire/ -- Woxsen University has released its…
Artelo Biosciences Announces New Data on ART12.11 Tablets Showing Improved Pharmacokinetics to Epidiolex
February 14, 2025 09:00 ET | Source: Artelo Biosciences SOLANA BEACH, Calif.,…